<DOC>
	<DOCNO>NCT01926652</DOCNO>
	<brief_summary>Clinical trial evaluate pharmacokinetic interaction safety single dose amlodipine 10mg candesartan 32mg combination dose amlodipine 10mg candesartan 32mg healthy male volunteer .</brief_summary>
	<brief_title>Safety Pharmacokinetics Study Amlodipine 10mg Candesartan 32mg</brief_title>
	<detailed_description />
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Male volunteer age 20 55 year old ( inclusive ) . 2 . Body weight &gt; = 55kg Body mass index ( BMI ) range calculate IBW ±20 % . 3 . Subjects without hereditary problem chronic desease . 4 . Subjects whose clinical laboratory test value inside accept normal range . 5 . Understand requirement study voluntarily consent participate study . 1 . Subjects history gastrointestinal disease might significantly change ADME medicine . 2 . Systolic blood pressure range ≥150 mmHg ≤ 100 mmHg diastolic blood pressure range ≥ 95 mmHg ≤ 60 mmHg . 3 . Subject symptom acute disease within 14days prior study medication dose . 4 . Subjects history clinically significant allergy amlodipin candesartan CCB medicine ( ex . aspirin antibiotic ) . 5 . Subjects galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption . 6 . Serum creatinine &gt; 1.2mg/dL . 7. smoke &gt; 10 cigarettes/day . 8. alcohol &gt; 210g/week . 9 . Positive test result drug test urin subject history substance abuse . 10 . Participation clinical investigation within 2 month prior study medication dosing . 11 . Subjects whole blood donation within 2 month , component blood donation within 1 month blood transfusion within 1 month prior study medication dose . 12 . Subjects consider unsuitable base medical judgement investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>